IP Library Granted Patent US 10,123,954
Granted Patent B1
US 10,123,954 · App. 16/106,388 · Granted Nov 13, 2018

Methods for treating skin

Inventors: Uma Santhanam (Tenafly, NJ); Jolanta Idkowiak-Baldys (Montebello, NY); Daniel Thorn Leeson (Chatham, NJ); Anthony D. Gonzalez (Oak Ridge, NJ); Glen T. Anderson (Pleasantville, NY)
Assignee: Avon Products, Inc.
A61K8/365A61K8/673A61K8/9789A61Q19/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,123,954
App. No.
16/106,388
Granted
Nov 13, 2018
Kind
B1
Abstract

Provided are methods of treating skin with at least two alternating treatment modalities to improve the health and/or diminish signs of aging. Some methods according to the present invention may comprise topically applying at least two separate compositions, in a sequential, rotating, or alternating fashion to overcome adaptation, tolerance, or sensitization phenomena.

Claims (31)

1. A method for diminishing dermatological signs of aging in human skin comprising, in any order, the steps of (1) topically applying to an area of the skin in need thereof, at least once daily, a first skin treatment composition comprising, in a physiologically compatible vehicle, an effective amount of a retinoid for a first period of time comprising from 2 to 15 days; (2) topically applying to said skin, at least once daily, a second skin treatment composition that is different from said first skin treatment composition for a second period of time comprising from 2 to 15 days wherein said second skin treatment composition comprises a moisturizer; and (3) repeating steps (1) and (2) for a number of times sufficient to diminish said dermatological signs of skin aging.

2. The method according to claim 1 , wherein said retinoid comprises retinol.

3. The method according to claim 1 , wherein said second skin treatment composition comprises a biological extract.

4. The method according to claim 3 , wherein said biological extract comprises an extract of a plant, yeast, or fungus.

5. The method according to claim 4 , wherein said extract of a plant, yeast, or fungus comprises an extract of Coleus forskohlii.

6. The method according to claim 1 , wherein said second skin treatment composition comprises phytol.

7. The method according to claim 1 , wherein said second skin treatment composition comprises an alpha-hydroxy acid or salt thereof.

8. The method according to claim 7 , wherein said alpha-hydroxy acid or salt thereof comprises glycolic acid or a salt thereof.

9. The method according to claim 1 , wherein said diminishing dermatological signs of aging is selected from the group consisting of:

(a) treatment, reduction, and/or prevention of fine lines and/or wrinkles;

(b) reduction of skin pore size;

(c) improvement in skin thickness, plumpness, and/or tautness;

(d) improvement in skin smoothness, suppleness and/or softness;

(e) improvement in skin tone, radiance, and/or clarity;

(f) improvement in procollagen, and/or collagen production;

(g) improvement in maintenance and remodeling of elastin;

(h) improvement in skin texture and/or promotion of retexturization;

(i) improvement in skin barrier repair and/or function;

(j) improvement in appearance of skin contours;

(k) restoration of skin luster and/or brightness;

(l) replenishment of essential nutrients and or constituents in the skin;

(m) improvement of skin appearance decreased by aging and/or menopause;

(n) improvement in skin moisturization;

(o) increase in skin elasticity and/or resiliency;

(p) treatment, reduction, and/or prevention of skin sagging;

(q) improvement in skin firmness;

(r) reduction of pigment spots and/or mottled skin; and

(s) improvement of optical properties of skin by light diffraction or reflection.

10. The method according to claim 1 , wherein said first period of time is 7 days, and said second period of time is 7 days.

11. The method according to claim 1 , wherein said first and second periods of time are consecutive such that one begins on the day following the last day of the other.

12. The method according to claim 1 , wherein said second skin treatment composition does not comprise an effective amount of a retinoid.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Jan 28, 2026
From: NATURA &CO LUXEMBOURG HOLDINGS S.À R.L., AS A SECURED PARTY; NATURA &CO UK HOLDINGS LIMITED, AS A SECURED PARTY
To: AVON PRODUCTS, INC.
Reel/Frame 074508/0281 →
RELEASE OF SECURITY INTEREST Recorded Dec 11, 2024
From: NATURA &CO HOLDING S.A.; NATURA COSMETICOS S.A.; NATURA &CO LUXEMBOURG HOLDINGS S.A R.L. - LUXEMBOURG; NATURA &CO UK HOLDINGS LIMITED - UK
To: AVON PRODUCTS, INC
Reel/Frame 069591/0494 →
PATENT SECURITY AGREEMENT Recorded Aug 16, 2024
From: AVON PRODUCTS, INC.
To: NATURA &CO HOLDING S.A.; NATURA &CO LUXEMBOURG HOLDINGS S.À R.L.; NATURA COSMÉTICOS S.A.; NATURA &CO UK HOLDINGS LIMITED
Reel/Frame 068659/0915 →
SECURITY INTEREST Recorded Aug 11, 2023
From: AVON PRODUCTS, INC.
To: NATURA &CO LUXEMBOURG HOLDINGS S.À R.L., AS A SECURED PARTY; NATURA &CO UK HOLDINGS LIMITED, AS A SECURED PARTY
Reel/Frame 064566/0872 →
SECURITY INTEREST Recorded Nov 14, 2019
From: AVON PRODUCTS, INC.
To: CITIBANK, N.A., LONDON BRANCH
Reel/Frame 051032/0210 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 21, 2018
From: SANTHANAM, UMA; IDKOWIAK-BALDYS, JOLANTA; THORN LEESON, DANIEL; GONZALEZ, ANTHONY DAVID; YADAV, PRADEEP H.; MARTINEZ-AVILA, OLGA MARIA; POLICELLI, LAUREN; ANDERSON, GLEN THOMAS; WYBORSKI, RUSSELL J.; DUTTON, SIMON; SCHOEN, JEANINE; VON BARGEN, DANA
To: AVON PRODUCTS, INC.
Reel/Frame 046642/0130 →
Continuity (4)
Continuation 15974106 · May 8, 2018
Continuation 15416791 · Jan 26, 2017
Continuation 15061678 · Mar 4, 2016
Provisional Application 62128647 · Mar 5, 2015
Cited By (1)
US 12,691,052